These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9086158)

  • 1. Human immunodeficiency virus infection and AIDS in a person with negative serology.
    Montagnier L; Brenner C; Chamaret S; Guétard D; Blanchard A; de Saint Martin J; Poveda JD; Pialoux G; Gougeon ML
    J Infect Dis; 1997 Apr; 175(4):955-9. PubMed ID: 9086158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection.
    Candotti D; Adu-Sarkodie Y; Davies F; Baldrich-Rubio E; Stirrups K; Lee H; Allain JP
    J Med Virol; 2000 Sep; 62(1):1-8. PubMed ID: 10935981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seronegative infection and AIDS caused by an A2 subsubtype HIV-1.
    Cardoso AR; Gonçalves C; Pascoalinho D; Gil C; Ferreira AF; Bártolo I; Taveira N
    AIDS; 2004 Apr; 18(7):1071-4. PubMed ID: 15096813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of detectable antibody in a patient infected with human immunodeficiency virus.
    Reimer L; Mottice S; Schable C; Sullivan P; Nakashima A; Rayfield M; Den R; Brokopp C
    Clin Infect Dis; 1997 Jul; 25(1):98-100. PubMed ID: 9243042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.
    Clerici M; Levin JM; Kessler HA; Harris A; Berzofsky JA; Landay AL; Shearer GM
    JAMA; 1994 Jan; 271(1):42-6. PubMed ID: 8258885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid development of AIDS in an HIV-1-antibody-negative homosexual man.
    Martin-Rico P; Pedersen C; Skinhøj P; Nielsen C; Lindhardt BO
    AIDS; 1995 Jan; 9(1):95-6. PubMed ID: 7893450
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of seronegative HIV-1 infection.
    Spivak AM; Brennan TP; O'Connell KA; Sydnor E; Williams TM; Siliciano RF; Gallant JE; Blankson JN
    J Infect Dis; 2010 Feb; 201(3):341-5. PubMed ID: 20039801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward an understanding of the correlates of protective immunity to HIV infection.
    Haynes BF; Pantaleo G; Fauci AS
    Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems in the diagnosis of AIDS].
    Matsushita S
    Rinsho Byori; 1994 Dec; 42(12):1248-52. PubMed ID: 7869588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human studies in the development of human immunodeficiency virus vaccines.
    Dolin R
    J Infect Dis; 1995 Nov; 172(5):1175-83. PubMed ID: 7594651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporary seronegativity in a human immunodeficiency virus type 1-infected man.
    Zaaijer HL; Bloemer MH; Lelie PN
    J Med Virol; 1997 Jan; 51(1):80-2. PubMed ID: 8986953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV seronegativity in an infant with the acquired immunodeficiency syndrome.
    Quiñonez JM; Begue RE; Steele RW
    South Med J; 1998 Sep; 91(9):879-81. PubMed ID: 9743066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
    Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa ML; Siccardi AG; Clerici M
    J Infect Dis; 1999 Sep; 180(3):871-5. PubMed ID: 10438383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection--evidence for highly susceptible human hosts.
    Michael NL; Brown AE; Voigt RF; Frankel SS; Mascola JR; Brothers KS; Louder M; Birx DL; Cassol SA
    J Infect Dis; 1997 Jun; 175(6):1352-9. PubMed ID: 9180174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity against HIV infection: lessons from HIV-2 infection.
    Rowland-Jones S
    Future Microbiol; 2006 Dec; 1(4):427-33. PubMed ID: 17661633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study.
    Cao H; Kaleebu P; Hom D; Flores J; Agrawal D; Jones N; Serwanga J; Okello M; Walker C; Sheppard H; El-Habib R; Klein M; Mbidde E; Mugyenyi P; Walker B; Ellner J; Mugerwa R;
    J Infect Dis; 2003 Mar; 187(6):887-95. PubMed ID: 12660934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A newly developed immunofluorescence assay for simultaneous detection of antibodies to human immunodeficiency virus type 1 and type 2.
    Tanabe-Tochikura A; Ang Singh MT; Tsuchie H; Zhang J; Paladin FJ; Kurimura T
    J Virol Methods; 1995 Apr; 52(3):239-46. PubMed ID: 7601900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.
    Beretta A; Weiss SH; Rappocciolo G; Mayur R; De Santis C; Quirinale J; Cosma A; Robbioni P; Shearer GM; Berzofsky JA
    J Infect Dis; 1996 Feb; 173(2):472-6. PubMed ID: 8568315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner.
    Promadej N; Costello C; Wernett MM; Kulkarni PS; Robison VA; Nelson KE; Hodge TW; Suriyanon V; Duerr A; McNicholl JM
    J Infect Dis; 2003 Apr; 187(7):1053-63. PubMed ID: 12660919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.